104
Views
1
CrossRef citations to date
0
Altmetric
Special Review: IL-6 inhibitor

“IL-6 is a treatment target for a variety of immune diseases”– The benefit and prospect of IL-6 inhibitor –

Page 257 | Received 13 Dec 2018, Accepted 13 Dec 2018, Published online: 01 Feb 2019

References

  • Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces Bc lymphocytes to produce immunoglobulin. Nature. 1986;324(6092):73–6.
  • Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22(5):347–52.
  • Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830–5.
  • Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, et al. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One. 2011;6(3):e17739.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.